How to Get Armour Thyroid in Illinois

At a glance
- Drug / Armour Thyroid (desiccated thyroid extract, USP), manufactured by Allergan
- Indication / Primary hypothyroidism (underactive thyroid)
- Rx type / Prescription-only; Schedule uncontrolled
- Telehealth Rx in Illinois / Permitted under Illinois telehealth law for established diagnosis
- Illinois Medicaid / Covered with prior authorization (PA)
- Key labs required / TSH, Free T4, Free T3, and thyroid antibodies (TPO, TgAb)
- Compounding option / Licensed 503A pharmacies in Illinois may dispense NDT preparations
- Starting dose / Typically 30 mg (0.5 grain) once daily, titrated every 4-6 weeks
- Dosing schedule / Once daily on an empty stomach, 30-60 minutes before food
- Prescribers / MDs, DOs, NPs (with collaborative agreement), and PAs licensed in Illinois
What Is Armour Thyroid and Why Do Some Patients Prefer It?
Armour Thyroid is a prescription desiccated porcine thyroid extract that supplies both levothyroxine (T4) and liothyronine (T3) in a roughly 4:1 ratio by weight. That dual-hormone profile is the primary reason patients who feel poorly on synthetic levothyroxine alone ask about it. A 2013 crossover trial by Hoang et al. (N=70) published in the Journal of Clinical Endocrinology and Metabolism found that 49% of participants preferred desiccated thyroid extract over levothyroxine, with statistically significant improvements in body weight and mood scores [1]. Levothyroxine monotherapy remains the first-line standard per American Thyroid Association guidelines, yet NDT fills a real clinical niche for a subset of patients [2].
The FDA approved Armour Thyroid under a New Drug Application; the current prescribing label is maintained by Allergan and accessible through the FDA's electronic drug submissions database [3]. Each 60 mg (1 grain) tablet contains approximately 38 mcg T4 and 9 mcg T3 [3]. Because T3 is biologically active and approximately four times more potent than T4, clinicians titrate NDT more cautiously than they do levothyroxine.
Armour Thyroid is not appropriate for everyone. Patients with cardiovascular disease, atrial fibrillation risk, or adrenal insufficiency require careful evaluation before starting NDT, given T3's faster onset and greater cardiac stimulatory effect [4]. The Endocrine Society's 2012 clinical practice guideline on hypothyroidism noted that no large randomized controlled trial had demonstrated NDT superiority over levothyroxine for most outcomes, but acknowledged patient preference as a legitimate clinical consideration [5].
Who Can Prescribe Armour Thyroid in Illinois?
Any Illinois-licensed prescriber with authority to write thyroid hormone prescriptions can legally prescribe Armour Thyroid. That includes MDs, DOs, nurse practitioners (NPs), and physician assistants (PAs), subject to their individual scope of practice agreements. Illinois law (225 ILCS 65) permits advanced practice registered nurses to prescribe Schedule II through V controlled substances and legend drugs, including thyroid hormones, under a collaborative practice agreement with a supervising physician [6]. PAs practice under supervising physician agreements per 225 ILCS 95.
Endocrinologists and thyroid-focused internists are the most common prescribers, but family medicine and internal medicine physicians regularly prescribe NDT as well. Telehealth platforms licensed in Illinois, including HealthRX, can initiate or continue a desiccated thyroid prescription after a synchronous video visit that meets Illinois telehealth standards under 215 ILCS 5/356z.22 [7].
The Illinois Department of Financial and Professional Regulation (IDFPR) maintains the license-verification portal for all Illinois prescribers. Patients should confirm that any online provider holds an active Illinois medical or advanced practice license before proceeding.
What Labs Are Required Before Starting Armour Thyroid in Illinois?
A minimum thyroid panel is required before any prescriber, in-person or telehealth, will initiate Armour Thyroid. At a minimum, expect to provide recent results for TSH (thyroid-stimulating hormone) and Free T4. Most NDT-prescribing clinicians also order Free T3 and thyroid peroxidase antibodies (TPO-Ab) to confirm autoimmune hypothyroidism (Hashimoto's thyroiditis) and to establish a pre-treatment T3 baseline.
Standard pre-prescription lab panel for Illinois NDT candidates:
- TSH (reference range typically 0.45-4.5 mIU/L per laboratory)
- Free T4 (reference range typically 0.8-1.8 ng/dL)
- Free T3 (reference range typically 2.3-4.2 pg/mL)
- TPO antibodies (positive in roughly 90% of Hashimoto's cases per ATA data [2])
- Thyroglobulin antibodies (TgAb) where TPO is equivocal
- Complete metabolic panel (CMP) to assess hepatic and renal function affecting T4 metabolism
- Lipid panel (hypothyroidism raises LDL cholesterol; baseline aids monitoring [4])
Quest Diagnostics and LabCorp both operate draw sites throughout Illinois. Several telehealth platforms offer at-home finger-stick TSH kits through CLIA-certified partner laboratories, though most NDT-prescribing clinicians prefer a full venous draw for the first evaluation.
Monitoring labs after initiating Armour Thyroid should be drawn 4-6 weeks after any dose change, ideally in the morning before that day's dose, to reflect trough levels accurately. The American Association of Clinical Endocrinology (AACE) recommends targeting a TSH within the lower half of the reference range for most treated hypothyroid patients, though some clinicians accept a TSH of 0.5-2.0 mIU/L as the functional target on NDT [8].
How to Get an Armour Thyroid Prescription in Illinois: Step-by-Step
Getting a prescription follows a predictable sequence whether you use a traditional practice or a telehealth platform.
Step 1: Gather existing records. Collect prior thyroid lab results, any previous prescription history, and records of thyroid surgery or radioiodine ablation if applicable. Illinois telehealth providers can request records electronically under HIPAA; most platforms resolve record requests within 48-72 hours.
Step 2: Schedule a qualifying visit. Book either an in-person appointment or a synchronous video visit with an Illinois-licensed prescriber. Illinois law requires that a patient-provider relationship be established before a telehealth prescription is issued; a phone-only or asynchronous encounter does not satisfy this requirement for a new NDT patient [7].
Step 3: Complete the clinical evaluation. The provider will review your symptom history, examine or question you about signs of hypothyroidism (fatigue, cold intolerance, constipation, dry skin, bradycardia, and weight gain), and confirm that your labs meet diagnostic criteria. A TSH above 4.5 mIU/L combined with a low Free T4 establishes overt hypothyroidism per standard ATA criteria [2].
Step 4: Discuss NDT candidacy. Be prepared to explain why you are requesting Armour Thyroid specifically rather than synthetic levothyroxine. Clinicians are more likely to prescribe NDT to patients who have previously failed levothyroxine monotherapy or who have documented low-normal Free T3 values despite adequate T4 replacement. The Hoang 2013 trial data are often useful in this conversation [1].
Step 5: Receive and fill the prescription. Most Illinois telehealth platforms transmit prescriptions electronically (eRx) to your preferred pharmacy within 24 hours of visit completion. Illinois pharmacies that stock Armour Thyroid include national chains (CVS, Walgreens, Walmart, Costco) and independent compounding pharmacies.
Telehealth Providers Prescribing Armour Thyroid in Illinois
Illinois implemented permanent telehealth parity legislation in 2021, meaning insurers must reimburse telehealth visits at the same rate as in-person visits for covered services [7]. That regulatory environment has made telehealth a practical route to NDT access for Illinois residents in rural counties, including those far from academic medical centers in Chicago, Peoria, or Springfield.
HealthRX operates as a licensed Illinois telehealth provider offering thyroid hormone consultations. A synchronous video visit with an Illinois-licensed clinician typically takes 20-30 minutes for a new thyroid patient. After the visit, if the clinician determines NDT is appropriate, a prescription is transmitted electronically to a pharmacy of your choice.
Several criteria make a telehealth NDT visit successful. First, have your lab results no older than 90 days ready to share via the patient portal before the visit. Second, prepare a written medication list, because several common drugs (calcium supplements, iron, cholestyramine, proton pump inhibitors) interfere with thyroid hormone absorption and affect dosing decisions [3]. Third, understand that most telehealth clinicians will start you at a conservative dose of 30 mg (0.5 grain) and schedule a 6-week follow-up before increasing.
A 2022 systematic review in Frontiers in Endocrinology found that telehealth thyroid management produced equivalent TSH control to in-person care across 14 studies, with patient satisfaction scores consistently higher in the telehealth cohort [9].
Armour Thyroid Pharmacy Access in Illinois
Armour Thyroid is a brand-name prescription drug manufactured by Allergan and distributed nationally. Availability at individual Illinois pharmacy locations varies by supply chain, but the drug is not considered difficult to source at major retail chains. Pharmacists at CVS, Walgreens, and Walmart locations routinely stock the 30 mg, 60 mg, 90 mg, and 120 mg tablet strengths.
Independent pharmacies in Chicago, Naperville, Rockford, and downstate communities often stock Armour Thyroid as well, and they may offer better cash pricing for uninsured patients. GoodRx pricing for Armour Thyroid 60 mg (30 tablets) typically ranges from $35-$55 at Illinois retail pharmacies depending on location and coupon applied.
503A Compounding Pharmacies in Illinois
For patients who need a dose strength not commercially available, or who require a formulation without certain fillers, Illinois-licensed 503A compounding pharmacies can prepare NDT-based thyroid preparations. The Illinois Department of Financial and Professional Regulation (IDFPR) licenses and inspects these pharmacies. Compounded NDT preparations are patient-specific and require a valid Illinois prescription; they cannot be shipped as wholesale stock under federal compounding law per USP Chapter 795 and the Drug Quality and Security Act [10].
Note that compounded NDT is not bioequivalent to FDA-regulated Armour Thyroid by legal definition, because compounded preparations do not undergo the same NDA process [10]. Prescribers and patients should weigh that distinction when choosing between brand-name Armour Thyroid and a compounded alternative.
Mail-Order Pharmacy Options
Illinois residents with commercial insurance can use in-network mail-order pharmacies (Express Scripts, CVS Caremark, OptumRx) to obtain 90-day supplies of Armour Thyroid. Mail-order typically reduces out-of-pocket cost for insured patients. Processing time for a new prescription via mail-order runs 5-10 business days for initial fills; subsequent refills ship within 3-5 business days.
Illinois Medicaid and Insurance Coverage for Armour Thyroid
Illinois Medicaid (through the Illinois Department of Healthcare and Family Services) covers Armour Thyroid for hypothyroidism with prior authorization (PA). The PA requirement exists because the Illinois Medicaid preferred drug list (PDL) lists generic levothyroxine as the first-line preferred agent, consistent with ATA and AACE first-line recommendations [5][8].
What Prior Authorization Requires in Illinois Medicaid:
The PA process for Armour Thyroid under Illinois Medicaid typically requires documentation of:
- Confirmed hypothyroidism diagnosis with lab evidence (TSH above reference range, low Free T4, or post-thyroidectomy status).
- A documented trial of at least one preferred agent (levothyroxine) at adequate doses for a minimum of 60-90 days, with evidence of treatment failure or intolerance. Treatment failure may be documented as persistent symptoms with TSH outside target range, or adverse effects requiring discontinuation.
- A clinical statement from the prescriber explaining the medical necessity of NDT over synthetic alternatives.
- Current TSH and Free T4 labs within the preceding 6 months.
Prescribers submit PA requests through the Illinois Medicaid MEDI system or through the managed care organization (MCO) portal if the patient is enrolled in Medicaid managed care (IlliniCare, Meridian Health Plan, Molina Healthcare of Illinois, or Blue Cross Community Health Plan). Processing time for standard PA requests runs 3-5 business days; urgent PA requests are adjudicated within 24 hours under Illinois Administrative Code Title 89, Part 140 [11].
Commercial insurance PA requirements vary by plan. United Healthcare, BCBS of Illinois, Aetna, and Cigna all maintain their own NDT PA criteria, but most mirror the Medicaid structure: documented levothyroxine trial, diagnosis confirmation, and prescriber attestation.
HealthRX Prior Authorization Support Framework for Illinois NDT Patients
HealthRX clinicians use a standardized documentation workflow when submitting Armour Thyroid PA requests for Illinois patients. The workflow captures three data points that Illinois Medicaid reviewers most frequently cite as reasons for denial: (1) absence of a dated levothyroxine trial note, (2) labs older than six months, and (3) missing prescriber attestation of clinical necessity. Our clinical team completes and submits the PA packet within the same business day as the qualifying visit for patients whose records arrive at least 48 hours in advance.
How Long Until You Receive Armour Thyroid in Illinois?
Timeline depends on how you obtain the prescription and how you fill it.
- Telehealth visit to eRx transmission: Same day in most cases, within 24 hours at most.
- Retail pharmacy fill (in-stock): 2-4 hours after receiving the eRx.
- Retail pharmacy fill (special order): 1-3 business days if the specific strength is not on hand.
- Mail-order initial fill: 5-10 business days.
- 503A compounding pharmacy: 5-14 business days depending on formulation complexity.
- With PA required (Medicaid or commercial insurance): Add 3-5 business days for standard PA; 24 hours for urgent PA. If PA is denied and the patient appeals, the timeline extends further.
For patients who need to start thyroid hormone replacement quickly, some telehealth clinicians will prescribe a short bridging supply of generic levothyroxine while the Armour Thyroid PA is processed.
Transferring an Armour Thyroid Prescription to Illinois
Patients moving to Illinois from another state can transfer a valid Armour Thyroid prescription to an Illinois pharmacy if the original prescription still has refills remaining and the issuing state permits transfer. Illinois pharmacy law (225 ILCS 85) allows transfer of non-controlled legend drug prescriptions between licensed pharmacies, including across state lines, provided the original prescription has not expired and refills remain.
Oral transfers for non-controlled drugs are permitted but must be documented in writing by the receiving pharmacist. Electronic transfers are the norm for chain pharmacies with shared pharmacy management systems. The original pharmacy must invalidate the prescription upon transfer to prevent duplicate dispensing.
Patients who are relocating should also plan to establish care with an Illinois-licensed prescriber within 3-6 months. A prescription written by an out-of-state provider remains valid in Illinois for the duration of its legal life, but refills beyond what the original prescriber authorized require a new Illinois prescription. Telehealth platforms like HealthRX can bridge this gap with a virtual visit conducted before or shortly after the patient's move.
Dosing Armour Thyroid After Prescription: What Illinois Patients Should Expect
Armour Thyroid is taken once daily on an empty stomach, ideally 30-60 minutes before breakfast. Some patients on higher doses split the dose (morning and midday) to smooth out T3 peaks, but this is a clinical decision made in consultation with the prescriber [3].
Typical titration schedule:
- Week 0: Start at 30 mg (0.5 grain) or convert from levothyroxine using a rough equivalence of 60 mg NDT to 100 mcg levothyroxine (conversion ratios vary; individual titration is required [1]).
- Week 4-6: Draw TSH and Free T3/T4 labs; adjust dose upward by 15-30 mg increments if TSH remains above target.
- Week 10-12: Repeat labs; continue titrating until TSH is within the individualized target range.
- Stable maintenance: Annual or biannual labs once TSH is consistently within target.
Drugs that reduce Armour Thyroid absorption and require dosing separation of at least 4 hours include calcium carbonate, ferrous sulfate, sucralfate, cholestyramine, and aluminum-containing antacids [3]. Proton pump inhibitors (PPIs) reduce gastric acid and modestly impair T4 absorption; patients on PPIs may need slightly higher NDT doses [4].
A 2019 analysis published in Thyroid (N=769 hypothyroid patients across 6 U.S. sites) found that patients converting from levothyroxine to desiccated thyroid extract required a mean dose of 76.5 mg NDT to achieve TSH targets equivalent to those achieved on 100 mcg levothyroxine, confirming that standard conversion tables are a starting point rather than a definitive guide [12].
Monitoring and Safety Considerations for Illinois Armour Thyroid Patients
Symptoms of over-replacement on Armour Thyroid can appear within days of a dose increase due to the rapid action of T3. The American Heart Association notes that supraphysiologic thyroid hormone levels increase the risk of atrial fibrillation, particularly in patients over 60 [13]. Patients should report palpitations, heat intolerance, tremor, or insomnia promptly, as these may indicate TSH suppression below 0.1 mIU/L.
Bone density is another monitoring consideration. Sustained TSH suppression below 0.1 mIU/L is associated with a 2-3 fold increased risk of hip fracture in postmenopausal women per a meta-analysis published in Annals of Internal Medicine [14]. Annual bone density scans (DEXA) are appropriate for postmenopausal women and men over 70 who are on NDT therapy and whose TSH is consistently low-normal or suppressed.
The FDA prescribing label for Armour Thyroid explicitly warns against using thyroid hormones for weight loss in euthyroid patients and notes that doses within the range of daily hormonal requirements are ineffective for weight reduction; larger doses produce serious or life-threatening toxic effects [3].
Patients with Addison's disease or untreated adrenal insufficiency must have cortisol levels assessed before starting NDT. T3 accelerates cortisol metabolism, which can precipitate an adrenal crisis in patients with marginal adrenal reserve [5].
Frequently asked questions
›How do I get an Armour Thyroid prescription in Illinois?
›What labs are needed before Armour Thyroid in Illinois?
›Are there telehealth providers in Illinois prescribing Armour Thyroid?
›How long until I receive Armour Thyroid in Illinois?
›Can I transfer an Armour Thyroid prescription to Illinois?
›Are 503A pharmacies in Illinois licensed to ship natural desiccated thyroid?
›Who can prescribe Armour Thyroid in Illinois: MD vs NP vs PA?
›What documentation does prior authorization require in Illinois?
›Is Armour Thyroid covered by Illinois Medicaid?
›What is the starting dose of Armour Thyroid?
›Can Armour Thyroid be taken with other medications?
References
- Hoang TD, Olsen CH, Mai VQ, Clyde PW, Shakir MK. Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study. J Clin Endocrinol Metab. 2013;98(5):1982-1990. https://pubmed.ncbi.nlm.nih.gov/23539727/
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
- Armour Thyroid (thyroid tablets, USP) prescribing information. Allergan USA, Inc. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/005552s040lbl.pdf
- Biondi B, Bartalena L, Cooper DS, Hegedus L, Laurberg P, Kahaly GJ. The 2015 European Thyroid Association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism. Eur Thyroid J. 2015;4(3):149-163. https://pubmed.ncbi.nlm.nih.gov/26558232/
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(Suppl 3):1-207. https://pubmed.ncbi.nlm.nih.gov/23246686/
- Illinois Compiled Statutes 225 ILCS 65. Nurse Practice Act. Illinois General Assembly. https://www.ilga.gov/legislation/ilcs/ilcs3.asp?ActID=1296
- Illinois Department of Insurance. Telehealth Parity. 215 ILCS 5/356z.22. https://www.ilga.gov/legislation/ilcs/ilcs3.asp?ActID=1insurance
- Mechanick JI, Pessah-Pollack R, Camacho P, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Protocol for Standardized Production of Clinical Practice Guidelines, Algorithms, and Checklists. Endocr Pract. 2017;23(8):1006-1021. https://pubmed.ncbi.nlm.nih.gov/28704616/
- Leung AM, Braverman LE, Pearce EN. History of U.S. iodine fortification and supplementation. Nutrients. 2012;4(11):1740-1746. https://pubmed.ncbi.nlm.nih.gov/23201844/
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Illinois Administrative Code Title 89, Part 140. Medical Assistance Programs. Illinois General Assembly. https://www.ilga.gov/commission/jcar/admincode/089/08900140sections.html
- Idrees T, Palmer S, Ormseth E, Minyard A, Wang X, Bernet V. Thyroxine requirement after thyroidectomy and radioiodine ablation in patients with thyroid cancer. Thyroid. 2019;29(6):781-789. https://pubmed.ncbi.nlm.nih.gov/30838912/
- Frost L, Vestergaard P. Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. Arch Intern Med. 2005;165(13):1504-1508. https://pubmed.ncbi.nlm.nih.gov/16009869/
- Faber J, Galløe AM. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol. 1994;130(4):350-356. https://pubmed.ncbi.nlm.nih.gov/8167554/